Target intelligence / Profile preview

Family with sequence similarity 124 member B (FAM124B)

Target
FAM124B
Molecular classification
Other (uncharacterized protein)
01

Overview

FAM124B is an emerging, largely uncharacterized protein found predominantly in the nucleus and nucleoplasm, and also in mitochondria[1]. It directly interacts with chromatin remodelers CHD7 and CHD8, implicating it in chromatin regulation, neurodevelopment, and disease processes such as CHARGE syndrome and acute myeloid leukemia[2][3]. Its expression is widespread in embryonic and adult mouse tissues, especially neural tissue, heart, and lung[4]. It shows significant methylation in hormone receptor–positive breast cancer and is associated with risk in metabolic/psychiatric conditions. No drugs target FAM124B, and its molecular function remains only partially described, with no recognized sequence domains or established roles for direct therapeutic intervention[1][3][4].

Other names
Protein FAM124BFAM124BFLJ22746Family with sequence similarity 124Bprotein FAM124B
02

Mechanism of action

Not applicable—no mechanisms of action for drug targeting have been reported for FAM124B

03

Biological functions

Regulation of chromatin structureGene expression modulationNeurodevelopment (especially as it interacts with chromatin remodelers CHD7 and CHD8)Other (potential epigenetic regulation in cancer tissues)
04

Disease associations

Neurodevelopmental disorders (possible involvement in CHARGE syndrome and autism spectrum disorders via interaction with CHD7/CHD8)Cancer (alterations in methylation status in breast cancer; proposed biomarker in acute myeloid leukemia)Psychiatric/metabolic conditions (association with anorexia nervosa via GWAS studies)
05

Safety considerations

None documented—no safety concerns or therapeutic challenges have been described; this is consistent with its lack of drug targeting
06

Biomarkers

Prognostic biomarker in acute myeloid leukemia (as part of transcriptomic risk scoring)Hypermethylation biomarker in estrogen/progesterone receptor–positive breast tumors

Beyond the preview

Go deeper on Family with sequence similarity 124 member B (FAM124B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 124 member B (FAM124B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call